SEC Form 4 · accession 0001209191-16-139195
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Lee R. McCracken
Director
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 6:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.46 | Aug 26, 2016 | A | 5,000 | A | — | Aug 25, 2026 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1One-third of the shares will vest on October 27, 2016 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of August 26, 2016.